3-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
Chemical Structure Depiction of
3-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
3-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
Compound characteristics
Compound ID: | L610-0290 |
Compound Name: | 3-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide |
Molecular Weight: | 488.63 |
Molecular Formula: | C29 H36 N4 O3 |
Smiles: | CC1CCN(CCCNC(c2cccc(CN3C(C4CCCN4C(c4ccccc34)=O)=O)c2)=O)CC1 |
Stereo: | RACEMIC MIXTURE |
logP: | 2.3451 |
logD: | -0.1152 |
logSw: | -3.1273 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 60.51 |
InChI Key: | BKLROGOHTCMFKW-SANMLTNESA-N |